| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/06/2005 | CN1635911A Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 07/06/2005 | CN1635909A Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient |
| 07/06/2005 | CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 07/06/2005 | CN1635906A Method of preventing cell death using antibodies to neural thread proteins |
| 07/06/2005 | CN1635903A Protease inhibitors |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635897A Photoprotective orally administrable composition for skin |
| 07/06/2005 | CN1635893A Use of a vitamin combination for the treatment of primary headaches |
| 07/06/2005 | CN1635891A Tetrahydroquinoline analogues as muscarinic agonists |
| 07/06/2005 | CN1635890A Neuroprotective 2-pyridinamine compositions and related methods |
| 07/06/2005 | CN1635889A Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
| 07/06/2005 | CN1635886A Method for treating diseases with omega interferon |
| 07/06/2005 | CN1635885A Improvement of nitric oxide synthase activity by using substituted indole compound |
| 07/06/2005 | CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists |
| 07/06/2005 | CN1635877A Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/06/2005 | CN1635864A Oligosaccharide aldonic acids and their topical use |
| 07/06/2005 | CN1635832A Method for administering GLP-1 molecules |
| 07/06/2005 | CN1634986A A novel Kunin type polypeptide and method for making same |
| 07/06/2005 | CN1634985A Pig Ghrelin derivative, its encoding gene and application |
| 07/06/2005 | CN1634962A Process for preparing synergy factor in artificial blood, nucleotide sequence used thereby |
| 07/06/2005 | CN1634566A Thymosin peptide oral tablet and its preparation method |
| 07/06/2005 | CN1634546A Health food prepared by spirulina, its extracts and traditional Chinese medicine and Tibet medicine |
| 07/06/2005 | CN1634541A Medicine for treating fatigue syndrome and preventing presenility, and preparation method thereof |
| 07/06/2005 | CN1634534A Anti-senescence bee medicine health care preparation |
| 07/06/2005 | CN1634506A Preparation prepared by biological chitin and traditional Chinese medicine for postponing senescence |
| 07/06/2005 | CN1634498A Diverse sagebrush granule as tea for relieving summer-heat and promoting digestion, and its preparation method |
| 07/06/2005 | CN1634454A 'Xingnaojing' freeze dried |
| 07/06/2005 | CN1634426A Composition of fresh rehmannia root and rhubarb horsetails and preparation method thereof |
| 07/06/2005 | CN1634385A Chinese traditional medicine composition for treating hydrocephalus, cerebral edema and intracranial hypertension |
| 07/06/2005 | CN1634384A Externally used washing lotion and preparation method thereof |
| 07/06/2005 | CN1634342A Soft capsule for activating pulse and preparation method thereof |
| 07/06/2005 | CN1634300A Oral anti-senescence health products |
| 07/06/2005 | CN1634284A Chinese traditional medicine for treating acute and chronic appendicitis |
| 07/06/2005 | CN1634162A Chinese medicine for treating various polyp, comprises confervoide oil |
| 07/06/2005 | CN1634145A 'Xingnaojing' dripping pills for treating cephalitis and hepatic coma and preparation process thereof |
| 07/06/2005 | CN1634124A Application of sodium hyaluronate in the process for preparing medical apparatus for preventing and treating adhesion due to pleurisy and pericarditis |
| 07/06/2005 | CN1634121A Dripping pills of ganoderma lucidum polysaccharide and polystictus versicolor polysaccharide |
| 07/06/2005 | CN1634075A Lycopene and coenzyme Q#-[10] containing formulation and its manufacturing method |
| 07/06/2005 | CN1634062A Nose cavity administering formulation of nalmefene |
| 07/06/2005 | CN1634019A Carbamaid peroxide freeze dried formulation for injection, its preparation method and uses |
| 07/06/2005 | CN1634015A Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
| 07/06/2005 | CN1209363C Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
| 07/06/2005 | CN1209361C Hydantoin-containing glucokinase activators |
| 07/06/2005 | CN1209359C Novel dihydric indole compound, their preparation process and medicinal compositions containing them |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/06/2005 | CN1209296C Method and apparatus for producing high functional water containing titanium |
| 07/06/2005 | CN1209172C Method for providing cosmetic/medical therapy |
| 07/06/2005 | CN1209166C Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance |
| 07/06/2005 | CN1209127C Application of yellowstem milkwort in preparing medicine for treating Meniere's Disease |
| 07/06/2005 | CN1209112C Smilagenin and anzurogenin-D for treating Alzheimer's disease |
| 07/06/2005 | CN1209111C Use of antiprogestins for the induction of apoptosis in a programming cell |
| 07/06/2005 | CN1209107C Carbazolyl alkaloid anticarcinogen and its prepn |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914122 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914072 E.g., ajulemic acid; used for decreasing cell proliferation |
| 07/05/2005 | US6914069 Pharmaceutically active compounds and methods of use |
| 07/05/2005 | US6914067 Compositions and methods for the treatment of colorectal cancer |
| 07/05/2005 | US6914064 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers |
| 07/05/2005 | US6914062 Pyrazinone derivatives |
| 07/05/2005 | US6914056 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 07/05/2005 | US6914044 Compounds and methods for modulating cell adhesion |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913749 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies |
| 07/05/2005 | CA2360677C Anticonvulsant derivatives useful in treating bulimia nervosa |
| 07/05/2005 | CA2327439C Combination therapy for the treatment of tumors |
| 07/05/2005 | CA2309485C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 07/05/2005 | CA2072541C Heterocyclic compounds, their production and use |
| 06/30/2005 | WO2005058951A1 Sugar chain-lacking hepatocyte growth factor |
| 06/30/2005 | WO2005012334A8 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 06/30/2005 | WO2005004926A8 Dendritic cell infiltrativity activating composition and immune activator |
| 06/30/2005 | WO2004078217A9 Bone calcification promoter |
| 06/30/2005 | WO2004078213A9 Composition for target substance introduction and method of target substance introduction |
| 06/30/2005 | WO2004065614A3 Suppression of cytotoxic protein conformers |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143596 Process for producing triterpene derivative |
| 06/30/2005 | US20050143583 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 06/30/2005 | US20050143578 Compounds and methods |
| 06/30/2005 | US20050143569 Polynucleotides, host cell expression systems, the encoded proteins, polypeptides and peptides |
| 06/30/2005 | US20050143467 Adjust fatty acid oxidation; stimulant carnitine palmitoly transferase |
| 06/30/2005 | US20050143466 drug delivery to infiltrate into spaces in skin; exposing skin to light energy to cause photosensitizing agent to become photodynamically activated; sebaceous gland disorder, sebum secretion, skin disorders |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143453 Selective preventing and therapeutic agents for progressive lesion after organic damage |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143423 Antiulcer; antisecretory; solubility, bioavailability; slow hydrolysis; full inhibition of acid secretion in oral therapy by prolonged presence in body; 1-(carboxythiophenesulfonyl)- 2-(substituted pyridylmethylsulfinyl) benzimidazoles; also with LANSOPRAZOLE, OMEPRAZOLE, PANTOPRAZOLE, or RABEPRAZOLE |
| 06/30/2005 | US20050143419 Guanidine and amidine derivatives as factor Xa inhibitors |
| 06/30/2005 | US20050143412 Controlled cessation of heart beat during cardiac surgeries by electrical stimulation of the vagus nerve and administration of a combination of drugs; improved surgical technique; Controlled intermittent asystole |
| 06/30/2005 | US20050143401 Anticancer agents; (4-(3-Fluorobenzyloxy)-3-chlorophenyl)-(6-(2-((2-methanesulphonyl-ethylamino)ethyl)-thiazol-4-yl)-quinazolin-4-yl)-amine |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143388 Nitric oxide donors for treatment of disease and injury |
| 06/30/2005 | US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/30/2005 | US20050143379 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |